Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Boston Biochem™ Recombinant Human Di-Ub/Ub2 WT Chains (K27-linked), CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems UC61B025
This item is not returnable.
View return policy
Description
The Recombinant Human Di-Ub/Ub2 WT Chains (K27-linked) is derived from E. coli. The Recombinant Human Di-Ub/Ub2 WT Chains (K27-linked) has been validated for the following applications: Bioactivity.Specifications
| P0CG47 | |
| 7314 | |
| 25μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after opening. | |
| DiUbiquitin | |
| 0.1 to 1μM | |
| Recombinant |
| 1mg/mL (58μM) in sterile, deionized water | |
| 17 kDa | |
| E. coli-derived human Di-Ubiquitin protein | |
| RUO | |
| Recombinant protein | |
| Unconjugated | |
| >95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain. Ub-AQUA analysis: K27: 95.9% K11: 3.9% All other linkages ≤ 0.05% |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
For Research Use Only.
Spot an opportunity for improvement?
Provide Content Correction